Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-04

Clinical Trial Update: Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial investigating armodafinil combined with neuro-rehabilitation to improve neurological recovery and reduce disability after stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Armodafinil (armodafinil)

Snippet

Sponsor: Burke Rehabilitation Hospital | Conditions: Stroke, Cerebrovascular Accident | Phase 2 | Status: COMPLETED | Results posted: 2019-11-04